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Mutations in TRPP2 (polycystin-2) cause autosomal dominant polycystic kidney disease (ADPKD), a common genetic disorder characterized
by progressive development of fluid-filled cysts in the kidney and other organs. TRPP2 is a Ca2+-permeable nonselective cation channel that
displays an amazing functional versatility at the cellular level. It has been implicated in the regulation of diverse physiological functions including
mechanosensation, cell proliferation, polarity, and apoptosis. TRPP2 localizes to different subcellular compartments, such as the endoplasmic
reticulum (ER), the plasma membrane and the primary cilium. The channel appears to have distinct functions in different subcellular
compartments. This functional compartmentalization is thought to contribute to the observed versatility and specificity of TRPP2-mediated Ca2+
signaling. In the primary cilium, TRPP2 has been suggested to function as a mechanosensitive channel that detects fluid flow in the renal tubule
lumen, supporting the proposed role of the primary cilium as the unifying pathogenic concept for cystic kidney disease. This review summarizes
the known and emerging functions of TRPP2, focusing on the question of how channel function translates into complex morphogenetic programs
regulating tubular structure.
© 2007 Elsevier B.V. All rights reserved.Keywords: Polycystic kidney disease; PKD2; Polycystin-2; Cilia; Ca2+; ADPKD1. Introduction
Many genetic diseases of ion channels, so called channelo-
pathies, have been identified in the past decade. Mutations in
over 60 ion channel genes are now known to cause human
disease [1]. Most channelopathies are rare disorders, but some,
like autosomal dominant polycystic kidney disease (ADPKD),
are among themost commonmonogenetic diseases known [2,3].
Mutations in the transient receptor potential channel TRPP2,
formerly known as polycystin-2, cause autosomal polycystic
kidney disease (ADPKD), a disease that is characterized by
progressive replacement of functional renal tissue with fluid-
filled cystic structures [4]. The function of the kidney critically
depends on the proper structure of its tubule system. Yet
regulation of tubular morphogenesis and diameter are poorly
understood phenomena. Cystic diseases of the kidney offer
unique opportunities to study these fundamental biological
processes.⁎ Tel.: +1 410 955 6281; fax: +1 410 614 8375.
E-mail address: koettgen@jhmi.edu.
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doi:10.1016/j.bbadis.2007.01.003Transient receptor potential (TRP) channels were first de-
scribed in Drosophila, where mutations in the trp gene caused a
transient response of photoreceptors to continuous light [5,6].
Unlike many other ion channels, most TRP channel family
members were identified by their homology rather than by
specific ligands or selectivity. Owing to this, their physiological
functions and activation mechanisms are diverse and often
unknown [7]. The members of the TRP superfamily of ion
channels share several common features including 6 transmem-
brane segments and permeability to cations (Fig. 2A) [7,8].
Nevertheless, the TRP family displays an amazing degree of
diversity in activation mechanisms, in selectivity and in
biological functions. Remarkably, a single TRP channel can be
activated through seemingly disparate mechanisms and inte-
grate multiple signals, as the response to one input is modified
by another. A common feature of most members of the TRP
channel family is that they have a role in sensory physiology,
but not just in the usual organismal definition, that is the five
Aristotelian senses. TRP channels are intrinsic sensors of the
cellular environment [8].
The TRP channel superfamily is divided into six subfamilies
on the basis of amino acid sequence homology (TRPC, TRPM,
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channels, the founding members of the TRPP and TRPML
subfamilies, TRPP2 and TRPML1, were identified in searches
for disease genes (ADPKD and Mucolipidosis type IV,
respectively) [4,9]. One of the most striking features of TRPP2
is its functional versatility. It has been implicated in cellular
processes as diverse as mechanosensation, proliferation, apop-
tosis, and polarity [10–12]. TRPP2 functions as a Ca2+-
permeable nonselective cation channel and assembles into a
receptor–channel complex with polycystin-1 [13,14]. This
protein complex forms the core of a signaling pathway that
uses Ca2+ as a second messenger. A fascinating question that
arises from the functional versatility of TRPP2 is how this
channel is able to fulfil its diverse physiological roles using a
promiscuous second messenger like Ca2+ and, at the same time,
ensure signaling specificity. To address these complex problems,
TRPP2 research needs to take place at the interface of ion
channel physiology, Ca2+ signaling, cell biology, developmental
biology, genetics, and clinical medicine, making this endeavor
equally challenging and exciting.
This review is not intended to provide a comprehensive
coverage of the extensive body of work on all aspects of the
genetics, biophysical properties, and trafficking of TRPP2,which
has been the topic of many excellent reviews [10,11,15–28].
Rather, it is attempted to integrate known and emerging functions
of TRPP2 at all levels of complexity, from single channel, to cell,
to the whole organism. Hence this review gravitates around the
central question of how TRPP2 channel activity translates into
the complex biological program that regulates tubule morpho-
genesis and maintenance.
2. Autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD)
is the most common monogenetic disease in humans. It affects
more than 1 in 1000 live births and is a common cause for
end stage renal disease (accounting for 7–10% of hemodia-
lysis patients, 500000 persons in the United States and 4–
6 million worldwide) [2,3]. Cysts arise as a focal outpouchFig. 1. The two-hit model of cyst formation in ADPKD. (A) Tubular epithelial cells
heterozygosity by a somatic mutation of the normal allele in an individual cell initiates
the cell in which both alleles are inactivated. (D) After disconnecting from its parent
secretion of electrolytes and water into the cyst lumen (modified from [168]).from any segment of the nephron, which eventually separate
from the parental nephron, and increase in size and number
throughout the patient's life [2,29]. The continuous increase of
fluid-filled cystic structures gradually replaces the normal
tissue resulting in end stage renal disease in ∼50% of the
patients by the sixth decade [2]. Although ADPKD is
characterized by kidney cysts and renal failure, it should be
regarded as a systemic disorder with cysts occurring in other
organs (liver, pancreas) and a range of cardiovascular
abnormalities (reviewed in [2]).
ADPKD results from mutations in PKD1 or PKD2 [30,31].
Mutations in either gene cause virtually indistinguishable
clinical presentations. The near identity of disease symptoms,
irrespective of the causative gene, suggests that the gene
products polycystin-1 and polycystin-2 (now TRPP2) function
in a common signaling pathway. This hypothesis is supported
by a variety of observations, including the similarity of
phenotypes between mouse knock-outs of either gene, the
discovery that the two proteins interact, and the identity of the
phenotypes caused by mutations in the homologous genes in
C. elegans.
The cyst epithelium is less differentiated than normal tubular
epithelial cells. Increased proliferation and fluid secretion are
thought to drive cyst growth [32,33]. Abnormalities in
apoptosis, cell polarity, gene expression, and extracellular
matrix have been implicated in the pathogenesis of ADPKD,
but the mechanism of cyst formation remains incompletely
understood [12,32,34–38]. Cyst development is a focal process
and it has been estimated that only around 1% of tubular cells
give rise to cysts [29]. A two-hit mechanism of cyst formation
has been proposed which explains the focal nature of cyst
development and the variability of the cystic phenotype [39,40].
According to this model, tubular epithelial cells that have
inherited a germline mutation in one allele of PKD1 or PKD2
acquire somatic mutations (second hits) of the normal allele,
which initiates cyst formation (Fig. 1).
Most cases of ADPKD (80–85%) are caused by mutations in
the PKD1 gene, which encodes polycystin-1 [31,41]. Human
polycystin-1 is a huge glycosylated protein that consists of 4302with a germline mutation in one TRPP2 allele form proper tubules. (B) Loss of
cyst formation (second hit indicated by the star). (C) Monoclonal proliferation of
al nephron, isolated cysts progressively increase in size due to proliferation and
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and other subcellular locations [14,42,43]. It is predicted to have
an extracellular N-terminal segment of 3000 amino acids, 11
transmembrane domains and an intracellular C-terminus of
∼200 amino acids (Fig. 2B). The extracellular portion includes
motifs commonly involved in protein–protein and protein–
carbohydrate interactions and a G-protein-coupled receptor
proteolytic site (GPS domain) [44,45]. The intracellular C-
terminus includes a coiled-coil domain that mediates binding to
TRPP2 [14,46,47], several predicted phosphorylation sites [41],
and a putative binding sequence for heterotrimeric G proteins
[48]. Although the in vivo function of polycystin-1 is still
unclear, it has been suggested to be a cell–cell or cell–matrix
adhesion receptor, and it might function as an atypical G protein
coupled receptor [48–50]. More recently, polycystin-1 has also
been proposed to function as a mechanosensor [51,52]. While
polycystin-2 has been recognized as a bona fide TRP family
member, polycystin-1 has been proposed to belong to this family
as well and the name TRPP1 was suggested [7]. This name is
probably misleading: although the last 6 transmembrane
domains display some sequence homology with TRPP2,
polycystin-1 does neither display structural nor functional
features of a TRP channel. The molecular genetics and function
of polycystin-1 have been extensively reviewed elsewhere
[12,34,53,54], and will therefore only be addressed here when
required for the understanding of TRPP2 function. Although
there has been considerable progress in the understanding of
some of the cellular functions of the polycystins, the
physiological functions of TRPP2 and polycystin-1 in vivo are
only now beginning to be unraveled.
3. TRPP2: identification and structural features
In 1996, Mochizuki et al. discovered the second locus
responsible for ADPKD on chromosome 4, mutated in∼15% ofFig. 2. Predicted structure of TRPP2 (A) and polycystin-1 (B). Protein mthe patients [30]. The PKD2 gene was identified by positional
cloning and encodes TRPP2 [30], a cation channel that is
evolutionarily conserved in vertebrates and invertebrates. In
addition to TRPP2, the TRPP family includes two other mam-
malian proteins referred to as TRPP3 (PKD2L1, polycystin-L,
PCL) [55,56] and TRPP5 (PKD2L2) [57,58]. TRPP2 homologs
have been found in yeast [59], sea urchins [60] C. elegans
[61,62], Drosophila [63,64], zebrafish [65–67] and mice [68].
TRPP2 is composed of 968 amino acids and contains 6 predicted
transmembrane domains (Fig. 2A). TRPP proteins share only
moderate amino acid identity to the most closely related TRPC
proteins, TRPC3 and TRPC6 [7]. Mammalian TRPP2 contains a
Ca2+-binding motif (EF-hand) and an endoplasmic reticulum
(ER) retention motif near the C-terminus, but does not include
any ankyrin repeats or a TRP domain like other TRP channels.
One structural feature that distinguishes TRPP2 from most other
TRP channel familymembers is a long extracellular loop between
the first and second predicted transmembrane segments (Fig. 2A).
TRPP2 is widely expressed in many tissues, including kidney,
heart, vascular smooth muscle, pancreas, intestine, bile ducts and
placenta. In the kidney, TRPP2 is expressed in all nephron
segments, but has not been detected in glomeruli [12]. TRPP2 has
been shown to localize to different subcellular compartments,
such as the ER [69,70], plasma membrane [71–73], primary
cilium [74], centrosome [75] and mitotic spindles in dividing
cells [76]. The functional implications of compartment-specific
TRPP2 channel activity will be discussed below (6.2).
4. TRPP2 channel function
The predicted topology of TRPP2 suggested that it might
function as an ion channel [30]. However, it took a surprisingly
long time until the first report on the channel function of TRPP2
was published [14]. The reason for the difficulties in measuring
channel activity in the plasma membrane was unraveled by Caiotifs are identified in the figure. Structures are not drawn to scale.
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ER, due to an ER retention motif in the C-terminal domain [69].
Truncation mutants in which this ER retention motif was
deleted, translocated to the cell surface where they could be
detected by immunofluorescence and electrophysiological
methods [69,77]. While the majority of studies detected no
channel activity of overexpressed full length TRPP2 in the
plasma membrane, two studies reported TRPP2 channel
function either upon treatment with chemical chaperones or
proteasome inhibitors [78], or upon massive overexpression that
may eventually override the ER retention machinery [79]. Even
though it is now generally accepted that TRPP2 functions as a
Ca2+- permeable nonselective cation channel, there is still
uncertainty regarding several important issues. One key
question is whether TRPP2 requires the presence of poly-
cystin-1 to form a functional channel. The first report on TRPP2
channel activity by Hanaoka et al. provided evidence that
polycystin-1 and TRPP2 interact to form a functional hetero-
meric complex [14]. In this study, it was shown that TRPP2
alone was unable to form functional channels in Chinese
hamster ovary cells. Co-expression of polycystin-1 and TRPP2,
however, promoted the translocation of TRPP2 to the plasma
membrane and gave rise to channel activity, with biophysical
properties similar to TRPP3 [14,80]. This finding was later
confirmed in neurons where overexpressed polycystin-1 and
TRPP2 formed a functional receptor-channel complex [13].
Channel activity was not observed when the C-terminal
interaction between polycystin-1 and TRPP2 was abrogated
by polycystin-1 truncation mutants, implying that co-assembly
of both proteins is required for TRPP2 channel function in the
plasma membrane [14]. Yet, whether polycystin-1 is a pore-
forming component of the channel complex or rather acts as a
“chaperone” is still unclear. Hanaoka et al. reported that a
TRPP2 truncation mutant (R742X), which does not bind
polycystin-1, translocates to the plasma membrane but displays
no channel activity, suggesting that TRPP2 channel function
requires polycystin-1 [14]. However, Delmas et al. reported that
the same truncation mutant gave rise to channel activity, with a
selectivity profile that was identical to the one of the polycystin-
1–TRPP2 complex [13]. Meanwhile several other studies
reported TRPP2 channel activity at the plasma membrane
without co-expression of polycystin-1 [77,78,81]. The differ-
ential cellular and subcellular localization of polycystin-1 and
TRPP2 also supports the idea that both proteins might have
independent functions in addition to their joint function [71].
Remarkably, a recent study reported that overexpression of
polycystin-1 gave rise to nonselective cation channel activity
that was independent of TRPP2, suggesting that polycystin-1
itself might function as a channel [82]. Although the last six
transmembrane domains of polycystin-1 share a moderate
degree of sequence homology with TRPP2, which might
constitute the structural basis for channel function, it cannot be
excluded that the currents induced by expression of polycystin-
1 were due to indirect effects on endogenous channels other
than TRPP2.
After the initial report on TRPP2 whole cell currents, several
single channel studies in placental preparations [79], Xenopusoocytes [78], HEK 293 cells [83], and in cell-free lipid bilayer
systems [79] characterized the channel properties in more detail.
Despite some discrepancies between these studies [17], it was
concluded that TRPP2 can form a functional channel in the
plasma membrane with constitutive activity upon overexpres-
sion. The detailed biophysical properties of the channel are
reviewed elsewhere [17,18]. In brief, TRPP2 showed a slightly
higher selectivity of Ca2+ over Na+ and K+, a high single
channel conductance (100–200 pS), and a relatively high
spontaneous open probability (20–40%) [17,18]. Koulen et al.
studied the single channel properties of ER-resident TRPP2
using reconstitution of microsomes in lipid bilayers [70]. This
study demonstrated that microsomal TRPP2 also functions as a
Ca2+-permeable nonselective channel. However, some of the
biophysical properties clearly differed from those reported for
TRPP2 in other studies [17,70,79]. While some of these
discrepant results (e.g. single channel conductance) may be
explained by technical differences in the experimental condi-
tions, others are more difficult to reconcile. These include the
very low spontaneous open probability of <1% in ER-micro-
some preparations compared to ∼20–40% in the plasma
membrane, the strong voltage dependence of TRPP2 which
was not observed consistently in other studies, and the variable
effects of C-terminal truncations on the single channel
conductance of TRPP2 [17,70]. Some of these differences
might be explained by interaction of TRPP2 with other proteins
that modulate its function. Since these interactions may depend
on factors like cell type, subcellular compartment, and
differentiation state, they can potentially account for the
discrepant results. However, it cannot be excluded to date that
some of the currents reported in the literature did not flow
through TRPP2, but through the pore of another channel that is
up-regulated or modulated by expression of TRPP2. The notion
that TRPP2 participates in pore formation, though very likely,
still awaits final proof by demonstration that the ion selectivity
of TRPP2 is altered by mutations in the putative pore-forming
region.
It is evident that future studies on TRPP2 channel function
will be required to learn more about potential regulatory
mechanisms, including the functional role of TRPP2 association
with other channels or regulatory proteins. Furthermore, the
identification of the physiological activation mechanisms and
specific inhibitors of TRPP2 will be critical to study its channel
function under more physiological conditions, i.e. in the native
tissue.
5. TRPP2-mediated signal transduction: versatile yet
specific
In the face of TRPP2's functional versatility how can
TRPP2-mediated signal transduction be specific? One of the
fundamental challenges of modern biology is to understand how
cells within a developing organism generate, integrate, and
respond to dynamic cues. Over the last decades, many pathways
of the responsible signal transduction networks have been
identified and functionally characterized. From this work, it has
become evident that a complicated interplay between signaling
Fig. 3. Model of TRPP2 function in intracellular Ca2+ signaling. (A) TRPP2 and
polycystin-1 form a signaling complex that uses Ca2+ as a second messenger.
Neither the activation mechanisms nor the Ca2+-regulated downstream effectors
are known. (B) Ca2+ is a multifunctional signaling molecule regulating a wide
array of downstream effectors, such as calmodulin-dependent kinases, different
protein kinase C isoforms, and calcineurin (drawn in blue, effector proteins are
schematized by various shapes). Multiple proteins, including G-protein-coupled
receptors and ion channels, regulate Ca2+ dynamics within a single cell (drawn
in red). Crosstalk between Ca2+ signaling pathways and other polycystin-1-
regulated signaling pathways (drawn in green) is likely to occur. (C) Ca2+
signaling microdomains are depicted as a red gradient around the channel pore.
These spatially restricted Ca2+ increases allow for the specific activation of
downstream effectors. Abbreviations: polycystin-1, PC-1; adenosine-trispho-
sphate, ATP; antidiuretic hormone, ADH; acetylcholine, ACh.
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levels of cross-talk, underlies even the “simplest” developmental
decision. Thus, a signaling pathway can no longer be thought of
as a rigid linear process, but rather must be considered a dynamic
and self-adjusting network.
Significant progress has been made in the identification of
signaling pathways by which TRPP2 and polycystin-1 exert
their physiological functions [12,18,34,84]. Polycystin-1 has
been reported to participate in various signaling pathways,
including the PI3 kinase pathway [85], the JAK/STAT pathway
[86], as well as Wnt- [87], mTOR- [88], NFAT- [89] and PKC-
pathways [90]. Some of these signaling functions of polycystin-
1 appear to require TRPP2, but it is not known how the different
pathways are integrated in vivo to regulate tubular morphogen-
esis and maintenance.
As mentioned above, multiple lines of evidence indicate that
TRPP2 and polycystin-1 function in a common signaling
pathway; in this review Ca2+ signaling shall be the focus.
Although it was predicted early on that the protein–protein
interaction between TRPP2 and polycystin-1 would promote
Ca2+-mediated signaling, this was formally demonstrated only
much later [13,14]. Meanwhile it is generally accepted that
polycystin-1 and TRPP2 form the core of a signaling pathway
that utilizes Ca2+ as a second messenger. However, neither the
activation mechanisms nor the effectors downstream of the Ca2+
signal have yet been identified (Fig. 3A). Ca2+ ions are
ubiquitous and versatile signaling molecules, capable of
decoding and integrating a variety of extracellular stimuli.
These stimuli are translated into diverse cellular actions ranging
from contraction, secretion, fertilization and proliferation to cell
death (reviewed in [91,92]). Multiple upstream and downstream
players in Ca2+ signal transduction are expressed within a single
cell (Fig. 3B). Thus, a fundamental question is how a given cell
is able to translate the wide array of extracellular signals into
specific cellular responses using the same second messenger.
The key to input-output specificity of this pleiotropic signaling
molecule is the complex spatiotemporal organization of Ca2+
signals, which allows specific effectors to be recruited [91,92].
Subcellular heterogeneity in Ca2+ concentration at rest and upon
stimulation, so-called cytosolic Ca2+ microdomains, are critical
for the selective activation of Ca2+-dependent effectors that
determine specific cellular responses (Fig. 3C) [93].
In the context of ADPKD this means that we need to
understand why loss of function of the Ca2+-permeable channel
TRPP2 causes such profound morphogenetic changes, whereas
related channels (e.g. TRPV5), permitting Ca2+ entry in the close
proximity (within a few micrometers), give rise to completely
different phenotypes when mutated, such as renal Ca2+ wasting
and reduced bone thickness in mice lacking TRPV5 [94]. In
order to understand TRPP2 signaling specificity, we need to
identify the activation mechanisms and downstream effectors of
TRPP2 that execute specific cellular functions. The multi-
functional properties of TRPP2 are likely to be mediated in part
by differential interactions with other proteins. In fact, TRPP2
has been shown to interact with different proteins including,
cytoskeletal proteins [95–97], adapter proteins [81,98,99], ion
channels [100], and others. Yet, the physiological relevance ofmost of these protein–protein interactions with TRPP2 remains
to be clarified. Moreover, in order to accomplish input–output
specificity in TRPP2-mediated signaling, there is probably
crosstalk between Ca2+ signals and other “polycystin-signaling”
pathways mentioned above (Fig. 3B). Current and potential
future experimental approaches to address these complex
problems will be discussed below. As a first step to elucidate
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laboratories have begun to study the compartment-specific
functions of TRPP2.
6. Compartment-specific functions of TRPP2
The long-standing debate whether TRPP2 resides and
functions in the plasma membrane or in the ER has been
reconciled by the recent demonstration that the subcellular
localization and transport of TRPP2 are controlled by
phosphorylation and multiple interactions with adapter proteins
[23,98,101–103]. Polycystin-1 [14], glycogen synthase kinase
3 (GSK3) [103] and Golgi- and ER-associated protein 14
(PIGEA-14) [98] have been shown to facilitate forward
transport of TRPP2 in the secretory pathway, whereas PACS-
2 and PACS-1 have been shown to mediate phosphorylation-
dependent retention or retrieval in the ER and Golgi apparatus,
respectively [81]. TRPP2 appears to serve distinct functions in
different subcellular compartments and its localization is
probably dynamically regulated (Fig. 4).Fig. 4. Compartment-specific functions of TRPP2. Various models for the localiza
function as a Ca2+-regulated Ca2+ release channel. TRPP2 channel activity in the
membrane or by interaction with the inositol 1,4,5-trisphosphate receptor (IP3-R) in th
complex with polycystin-1. This complex resides either at the basal cell–matrix inter
TRPP2 may function as a sensor for mechanical or chemical cues. Flow-mediated be
was proposed to require the TRPP2–polycystin-1 complex. Other members of the TRP6.1. TRPP2 function in the plasma membrane
Functional expression of TRPP2 in the plasma membrane
was first reported by Hanaoka et al. and subsequently
confirmed by others using different overexpression systems
[13,14,72,79,81]. Furthermore, the activity of endogenous ion
channels with biophysical properties similar to overexpressed
TRPP2 has been detected in several cell types [72,83,104].
Based on the finding that TRPP2 and polycystin-1 interact in
vitro and in vivo, it was suggested that both proteins could
form a receptor–ion channel complex that senses extracellular
cues and translates them into intracellular Ca2+ signals. In this
model, binding of hitherto unidentified ligands to polycystin-1
would regulate the gating of TRPP2. Delmas et al. provided
evidence supporting this concept by showing that polycystin-
1–TRPP2 complexes reconstituted in neurons can be activated
by applying antibodies directed against the receptor for egg
jelly (REJ) domain of polycystin-1 [13]. This elegant study
revealed striking mechanistic parallels with the acrosome
reaction in sea-urchin spermatozoa [105]. The acrosometion-dependent functions of TRPP2 are depicted. (A) In the ER, TRPP2 may
ER might be regulated by interaction with polycystin-1 (PC-1) in the plasma
e ER. (B) In the basolateral plasma membrane TRPP2 is thought to function in a
face or at cell–cell junctions in the lateral membrane. (C) In the primary cilium
nding of the cilium was shown to trigger cytosolic Ca2+ signals, in a process that
family (TRPV4 and TRPC1) may also be involved in ciliary mechanosensation.
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orthologs which bind components of egg jelly [106].
Antibodies directed against the REJ domain of sea urchin
REJ proteins induce the acrosome reaction by opening sperm
Ca2+-permeable channels of unknown identity [107]. Delmas et
al. suggested that polycystin-1 activates TRPP2 via conforma-
tional coupling, since the REJ antibodies increased whole cell
currents independent of G protein and phospholipase C
signaling [13]. However, it is also possible that TRPP2 can
be activated indirectly by polycystin-1 under certain condi-
tions. Recently, it has been reported that TRPP2 channel
activity can be enhanced in response to epidermal growth factor
(EGF) receptor stimulation [108], in a process that is mediated
via phospholipase C (γ2) and phosphoinositide 3-kinase (PI3-
kinase). Since polycystin-1 was shown to increase PI3-kinase
activity in another study [85] one might hypothesize that
polycystin-1-induced PI3-kinase activity may regulate TRPP2,
providing an indirect activation mechanism that does not
require physical interaction between polycystin-1 and TRPP2.
In tubular epithelial cells TRPP2 has been shown to localize to
the basolateral membrane [71,73] and it has been suggested
that polycystin-1–TRPP2 complexes at cell–matrix or at cell–
cell junctions in the basolateral membrane may regulate
processes like adhesion, differentiation and proliferation (Fig.
4B). However, experimental evidence supporting the functional
relevance of this model is still sparse.
6.2. TRPP2 function in the ER
After it was reported that native and transfected TRPP2
accumulated in the ER [69], an obvious question was whether
the channel also functions in this subcellular compartment. Ion
channel function in the ER is well established for the IP3
receptor and the ryanodine receptor. For most ion channels,
however, intracellular compartments, including ER and Golgi
apparatus, have been viewed as “whistle stops” on the way to
their final functional destination, the plasma membrane. Recent
studies have revealed that members of other ion channel
families, like ClC chloride channels, which had been thought to
function in the plasma membrane exclusively, have important
intracellular functions [109]. Koulen et al. reported that TRPP2
may function as a Ca2+ release channel in the ER, which
amplifies Ca2+ transients triggered by IP3 [70] (Fig. 4A).
TRPP2, reconstituted in lipid bilayers, appears to be directly
activated by Ca2+ and the open probability displays a bell-
shaped Ca2+ dependence [70]. The sensitivity of microsomal
TRPP2 to Ca2+ stimulation was shown to be significantly
increased by phosphorylation of S812, a putative CK2 phos-
phorylation site [110]. Recently, it has been reported that
TRPP2 interacts physically and functionally with the IP3
receptor in an Xenopus oocyte expression system and it has
been proposed that this interaction is critical for TRPP2 function
in the ER [111]. Furthermore, vascular smooth muscle cells of
TRPP2+/- mice were reported to display altered intracellular
Ca2+ homeostasis, which may potentially be linked to TRPP2
channel function in the ER [112]. Although the physiological
relevance of TRPP2 channel function in the ER remains to beclarified, the existence of other ER-resident “cystoproteins” like
bcl-2 [113], PRKCSH (glucosidase II β subunit) [114] or
SEC63 [115] points to a potential role of the ER in cystogenesis.
Unpublished results from our laboratory indicate that TRPP2
may regulate the Ca2+ concentration in the ER and thereby
control apoptosis sensitivity, a critical cellular function for
tubule morphogenesis and tissue homeostasis (see also 7.1).
6.3. TRPP2 function in the primary cilium
An amazing convergence of findings from several species,
including algae, nematodes, fruit flies and mice implicate
defects in structure or function of primary cilia as a possible
common mechanism in the development of polycystic kidney
disease [116–118]. The primary cilium is an antenna-like
structure that emanates from the surface of virtually every cell in
the mammalian body and functions as a sensory organelle
[119,120]. Ultrastructurally, cilia consist of a ciliary membrane
that is continuous with the cell membrane and a central
axoneme that is composed of microtubules. The cilia axoneme
originates from the basal body, a centriole-derived microtubule-
organizing center [117,119]. The role of cilia in sensing the
extracellular environment is best understood in the context of
olfaction and photoreception. In addition to sensing chemicals
and light, cilia can sense mechanical cues. These functions have
been well characterized in model organisms. Ciliary TRPV
channels in Drosophila and C. elegans may function as
mechanosensors. In Drosophila, two TRPV channels (Inactive
and Nanchung) on the cilia of auditory neurons mediate
reception of sound vibrations at the antenna [121,122], and the
TRPN channel NOMPC is required for touch sensation in
mechanosensory bristles [123]. Similarly, two C. elegans TRP
channels (OSM-9 and OCR-2) localize to cilia of sensory
neurons, where they respond to nose touch, chemicals and high
osmolarity [124]. The functional importance of renal cilia has
been largely ignored until a series of recent studies suggested
that structural or functional ciliary defects are associated with
cystic kidney disease [62,125,126]. The first hint that cilia
might be involved in cystogenesis in the kidney came from the
orpk mouse model of PKD. The orpk phenotype is caused by a
hypomorphic allele of the Tg737 gene, and is characterized by
multiple abnormalities including cystic kidneys [127]. The
discovery that Tg737 is the mouse homolog of IFT88, a protein
required for the assembly of flagella in the green algae, Chla-
mydomonas reinhardtii, was a breakthrough linking structural
abnormality of cilia to the development of PKD [125]. In
addition, around the same time it was shown that the C. elegans
homologs of TRPP2 (pkd-2) and polycystin-1 (lov-1) localize to
cilia in sensory neurons and function in a common pathway,
regulating male mating behavior [61,62]. Remarkably, it was
shown in several studies that the majority of mammalian
cystoproteins including TRPP2 and polycystin-1 are localized
to primary cilia in the kidney [74,128]. None of the human PKD
genes appears to be associated with assembly of cilia. Rather
PKD patients form cilia that are normal in appearance, but are
missing proteins required for sensory transduction. In the
kidney the primary cilium would be ideally positioned to act as
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lumen. But what is it that the cilium is sensing? Based on elegant
studies by Praetorius and Spring it was proposed that renal cilia
function as mechanosensors that detect fluid flow in the tubule
lumen. The bending of cilia on MDCK cells by laminar fluid
flow or a micropipette led to an increase in the cytosolic Ca2+
concentration that was strictly dependent on the presence of cilia
[129,130]. This calcium influx through an unknown ciliary ion
channel triggered Ca2+-induced Ca2+ release from the ER which
amplified the signal [129]. Subsequently it was shown by Liu et
al. that flow-mediated Ca2+ signals in isolated microperfused
collecting ducts of orpk mice (which have stunted cilia) were
decreased compared to wild type animals [131], supporting the
flow-hypothesis in a more physiological experimental setting.
The Ca2+ permeability and localization of TRPP2 make it an
attractive candidate for a ciliary Ca2+ entry pathway (Fig. 4C).
Nauli et al. presented the first evidence that polycystin-1 and
TRPP2 might be involved in flow sensing, using cells derived
from mice lacking polycystin-1 [51]. In this study polycystin-1-
deficient cells did not show an increase in the cytosolic Ca2+
concentration in response to fluid flow. Furthermore, antibodies
directed against the first extracellular loop of TRPP2 (between
transmembrane segments 1 and 2) abolished the flow response in
wild type mice [51]. Interestingly, an antibody directed against
an intracellular epitope that served as a negative control also
blocked about 50% of the flow-induced Ca2+ signal. As an
independent indication for the involvement of TRPP2 in the flow
response the authors reported that TRPP2 is not detectable in
cilia of polycystin-1-deficient cells. This observation, however,
is at odds with a recent study showing that an N-terminal motif in
TRPP2 is responsible for its targeting to the primary cilium in a
process that did not require polycystin-1 [101]. The notion that
TRPP2 is part of a flow-mediated Ca2+ entry pathway in the
primary cilium of tubular epithelial cells would be strengthened
by the demonstration that the flow-induced Ca2+ signal is
reduced or abolished in TRPP2-deficient cells. A recent study
was the first to provide evidence for single channel cation
currents from isolated primary cilia [132]. However, the
molecular identity and mechanosensitivity of these ciliary
channels remains to be established. Another hint for a potential
role of TRPP2 in ciliary mechanosensation was revealed by a
recent unexpected observation. Pennekamp et al. found that
targeted disruption of TRPP2 in mice causes situs inversus, in
addition to the known abnormalities in the kidney and the
cardiovascular system [133]. The establishment of left–right
asymmetry of visceral organs is known to require directed fluid-
flow in an embryonic structure called the node [134]. Consistent
with a potential mechanosensory role of TRPP2 it was
subsequently reported that the channel is expressed in cilia of
the embryonic node, where it appears to be required for the
transduction of leftward nodal fluid flow into perinodal Ca2+
signals [135]. Interestingly, none of the polycystin-1-deficient
mouse strains have been reported to exhibit laterality defects,
which correlates with the absence of polycystin-1 in nodal cilia.
This supports the view that, at least in the embryonic node,
TRPP2 may be involved in mechanosensation in the absence of
polycystin-1. However, recent evidence suggests that nodal flowresults in morphogen transport via nodal vesicular particles,
which is supposedly critical for the generation of laterality [136].
In this model asymmetric elevation of intracellular Ca2+ in the
node is caused by chemical rather than mechanical cues [134].
Overall, there is some evidence to support the model that the
polycystin-1–TRPP2 complex may function as a mechanosen-
sor that transduces mechanical stimuli into intracellular Ca2+
signals. However, direct experimental evidence demonstrating
that the polycystin-1–TRPP2 complex is mechanosensitive is
still missing.
The mechanism whereby mechanical force is transduced to
regulate the activity of TRPP2 is currently unknown. Since
there is no experimental evidence indicating that homomulti-
meric TRPP2 channels are mechanosensitive, one may
hypothesize that TRPP2 assembles with other TRP channels
to form a heteromeric mechanosensitive channel complex. This
would be consistent with observations in C. elegans, whereby
differential assembly of heteromeric TRP channel complexes
specifies distinct sensory modalities including mechanosensa-
tion [124]. Unpublished results from the Delmas group and
from ourselves indicate that TRPP2 might in fact assemble with
two candidate TRP channels, TRPC1 and TRPV4, to form a
mechanosensory complex (Fig. 4C) (reviewed in [20]).
An alternative function of the primary cilium in the kidney
may be in sensing the concentration of specific ligands in the
tubule lumen. In such a chemosensory model, binding of ligands
to polycystin-1 might regulate the gating of TRPP2, resulting in
intracellular Ca2+ signals. Both models could potentially convey
spatial information to the tubular epithelial cell, which is
required to form and maintain a polarized epithelial tube with
proper diameter [137]. Future studies will have to test whether
chemical, mechanical, or both types of stimuli are essential to
transduce morphogenetic signals via TRPP2.
Taken together, TRPP2 has been shown to function in at least
3 different subcellular localizations, the plasma membrane, the
ER, and the primary cilium (the possibility of TRPP2 function at
mitotic spindles is discussed elsewhere [76]). It remains to be
determined which pool of TRPP2 is critical for the pathogenesis
of ADPKD. For obvious reasons the PKD field has become quite
ciliocentric recently. However, one should not exclude the
possibility that an interplay between different compartment-
specific functions of TRPP2 (and other cystoproteins) is critical
for the underlying physiological and pathophysiological pro-
cesses. The flow-induced Ca2+ signal is a good example for the
interaction between two compartments, the cilium and the ER,
since either compartment-specific component of the Ca2+ signal
is critical to transduce the mechanical stimulus [129].
6.4. Activation mechanisms
The different localization-dependent functions described
above have provided first insights into the activation mechan-
isms of TRPP2, which are essential for understanding the
physiological function of the channel. In the ER, it has been
suggested that Ca2+ directly activates TRPP2 [70], but the
nature of the physiological stimulus that triggers the Ca2+
increase is not clear in this context. In the primary cilium
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a complex with other proteins [51]. In the plasma membrane
activation via EGF receptors and polycystin-1 has been reported
[13,108]. One of the most important future challenges will be
the identification of polycystin-1 or TRPP2 ligands, which will
enable us to study the spatiotemporal aspects of TRPP2 function
and Ca2+ signaling in more physiological settings.
6.5. Downstream effectors
The identity and regulation of Ca2+-dependent downstream
effectors in the TRPP2 signaling pathway are even less
understood. Recently, it was reported that TRPP2 binds the
pro-proliferative helix–loop–helix protein Id2 and prevents it
from entering the nucleus [138]. Mutations in TRPP2 that
disrupt the binding of Id2 were reported to cause nuclear
translocation of Id2, resulting in increased proliferation. It is
unknown whether this process is regulated by TRPP2-
dependent Ca2+ signals. Furthermore, several polycystin-1-
induced downstream signals, including NFAT activation [89],
the nuclear translocation of the polycystin-1 C-terminal domain
[139], and the JAK/STAT pathway [86] have been shown to
depend on TRPP2. Yet, in none of these examples a direct link
to TRPP2-dependent Ca2+ signals has been established.
Consequently, in order to understand TRPP2 Ca2+ signaling
specificity, it will be mandatory to identify Ca2+-dependent
downstream targets in the TRPP2 signaling pathway.
7. Cellular consequences of TRPP2 function
The physiological functions of TRPP2 have been mostly
deduced from the loss of function phenotypes observed in cells
and tissues of patients and animal models. As mentioned earlier
TRPP2 has been implicated in the regulation of cellular
differentiation, proliferation, apoptosis, and polarity. Conse-
quently, a fundamental question is how TRPP2 fulfils such
diverse physiological functions.
7.1. Apoptosis
Processes that disrupt the delicate balance between the rates
of cell proliferation and apoptosis have been reported to result in
cyst formation [140,141]. Apoptosis is increased in polycystic
kidney disease and there is ample evidence that apoptosis plays a
causal role in cyst formation [142]. Tubular epithelial cell
apoptosis is increased early on in most animal models of PKD
and in kidneys from humans with ADKPD [143,144]. Induction
of apoptosis results in cyst formation in tubular epithelial cells in
3D collagen culture, and cystogenesis in this system is inhibited
by overexpression of the antiapoptotic protein Bcl-2 [145].
Moreover, a recent study demonstrated that caspase inhibition
reduces apoptosis and proliferation in renal epithelia and
attenuates cyst formation and kidney failure in PKD animal
models [143]. Although the link between apoptosis and PKD is
well established, our understanding of the molecular mechan-
isms of apoptosis regulation by TRPP2 is still sketchy. Recent
studies have emphasized the central role of Ca2+ in theregulation of programmed cell death [146,147]. Increases in
cytosolic Ca2+ during cell death can arise from several sources,
including damage of external membranes, hyper-activation of
cation channels or release from Ca2+ stores in the ER [146, 148].
Apoptotic stimuli such as thapsigargin or ceramide elicit Ca2+
release from the ER and thereby increase the mitochondrial Ca2+
concentration [149], which results in induction of apoptosis. Kip
et al. reported increased rates of apoptosis in vascular smooth
muscle cells of TRPP2+/− mice and suggested that this
phenotype is caused by a reduction in the cytosolic Ca2+
concentration in these cells [150]. However, the mechanistic link
between the Ca2+ reduction and increased apoptosis is not clear.
Preliminary results from our group indicate that TRPP2 function
in the ER protects cells from apoptosis by decreasing the con-
centration of releasable calcium in the ER [151], a well-es-
tablished determinant controlling apoptosis sensitivity [149].
This exemplifies that compartmentalized TRPP2 channel
function appears to be critical for specific cellular outcomes.
Moreover, these results may explain the rather counterintuitive
concept that a nonselective cation channel protects cells from
apoptosis rather than killing them. Interestingly, polycystin-1
has also been shown to protect cells from apoptosis via the
phosphatidylinositol 3-kinase (PI3-kinase)/Akt signaling path-
way [85,140]. Future studies will have to address whether TRPP2
and polycystin-1 function in a common pathway of apoptosis
regulation.
7.2. Proliferation
The prevailing model of cystogenesis in ADPKD predicts
that the loss of heterozygosity following a somatic mutation of
the wild type allele of PKD1 or PKD2 causes monoclonal
proliferation of cells and thereby initiates cyst formation (Fig.
1). Evidence to support this hypothesis has come from
microdissection studies of cystic kidneys, which revealed that
cyst size is due to an increase in the number of epithelial cells
lining the cyst and not to the stretching of the cyst wall [152].
Additionally, cultured epithelial cells from ADPKD cysts
display enhanced rates of proliferation, and genes associated
with increased proliferation, such as c-Myc, have been found to
be overexpressed in cystic epithelium [153,154]. TRPP2 has
also been implicated in regulation of the cell cycle via its
calcium channel activity and stimulation of the transcription
factor AP-1 [155]. However, there has been little direct evidence
tying TRPP2 to this process. Several groups have studied the
role of TRPP2 in the regulation of proliferation using both, loss
and gain of function approaches. Grimm et al. created a number
of cell lines variable in their expression of TRPP2 to
demonstrate that that the basal and EGF-stimulated rate of
cell proliferation is higher in cells that do not express TRPP2
versus those that do [156]. This indicates that TRPP2 acts as a
negative regulator of cell growth. Cells expressing a channel
dead mutant of TRPP2 (D511V) proliferated faster than those
expressing the wild-type protein, implying that channel activity
of TRPP2 may be important in this process [156]. A recent
study reported that haploinsufficiency of TRPP2 can result in
increased tubular proliferation in the cystic kidney [157]. Since
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non-cystic tubules, the authors concluded that it probably
represents one of the earliest events in cyst formation. Another
study in lymphoblastoid cell lines suggested that loss of TRPP2
in these cells is associated with reduced proliferation, a finding
that seems at odds with other studies [158]. The fact that these
data were obtained from non-renal cells suggests that TRPP2
may play specific growth regulatory roles in epithelial cells that
are not recapitulated in non-epithelial cell types. In addition, the
association of TRPP2 with polycystin-1 suggests that TRPP2
may be involved in some of the same growth suppression
pathways that have been attributed to polycystin-1 [140]. Work
by Bhunia et al. in particular indicates that polycystin-2 aids
polycystin-1 in its antiproliferative function via up-regulation of
the cell cycle arrest protein p21waf1 [86]. In summary, there is
mounting evidence to support an anti-proliferative role for
TRPP2 but the mechanistic link to TRPP2 channel function
remains to be established.
7.3. Polarity
In addition to apico-basolateral polarity of epithelia there is a
second polarity axis in the plane of the epithelium. In contrast to
a renal tubule, which possesses clearly distinct longitudinal and
circumferential axes, a cyst has no predominant axis. In
epithelial tissues it appears that individual cells are able to
identify their position and orientation relative to the overall
orientation of the epithelial sheet through a process termed
planar cell polarity [159]. The transition from tubule to cyst in
ADPKD suggests a profound alteration in this process. The
fundamental determinants of planar polarity have been studied
in Drosophila and the non-canonical Wnt signaling pathway
appears to play a central role in this process [159].More recently,
different studies provided first insights that alterations in planar
cell polarity might in fact be central to cyst development
(reviewed in [160,161]). Fischer et al. elegantly showed that
lengthening of renal tubules is associated with mitotic orienta-
tion of cells along the tubule axis, demonstrating intrinsic planar
cell polarization [162]. Moreover, they demonstrated that
mitotic orientations are significantly distorted in rodent poly-
cystic kidney disease models, suggesting that oriented cell
division dictates the maintenance of constant tubule diameter
during tubular lengthening and that defects in this process trigger
renal tubular enlargement and cyst formation. In addition,
Simons et al. provided experimental evidence that links cilia
with noncanonical Wnt signaling pathways and planar polarity
[163]. This exciting study suggested that the ciliary cystoprotein
inversin might act as a flow-regulated molecular switch between
canonical and noncanonical Wnt pathways. Notably, loss of
inversin function in mice and humans, like TRPP2 disruption,
results in left–right axis defects and severe renal cystic disease
[164]. The link between flow-mediated Ca2+ signals and
inversin is not clear to date, but it is tempting to speculate that
local Ca2+ signals modulate inversin function. Interestingly,
inversin contains an IQ motif and has been shown to bind
calmodulin in a Ca2+-dependent fashion, supporting this
hypothesis [165]. How TRPP2 tranduces spatial cues todownstream effectors like inversin to regulate polarity will be
an exciting future area of research.
The mechanism by which the diverse cellular defects
discussed here ultimately initiate cystogenesis is unclear. The
integration of apoptosis, proliferation, and polarity regulation at
the tissue level may be critical to understand cyst development.
In contrast to the role of increased proliferation in cystogenesis,
that of apoptosis appears rather counterintuitive, since kidney
size is hugely increased in ADPKD. However, a significant
portion of the volume increase is due to cyst fluid rather than
increase in cyst tissue. Therefore, a subtle imbalance between
cell proliferation and apoptosis is probably sufficient for cyst
development and growth. One might speculate that as a result of
increased apoptosis, regenerating cells need to orient them-
selves in the epithelial layer with correct apico-basolateral and
planar polarity. Thus, alterations of apoptosis, proliferation and
polarity signaling might jointly cause cyst development.
8. TRPP2 function in vivo: lessons from animal models
Homozygous TRPP2 knockout mice are embryonic lethal
and develop severely cystic kidneys in utero [68]. Besides cysts
these animals exhibit a range of nonrenal manifestations that are
not seen in human ADPKD, including abnormal vascular
permeability, defective cardiac septation and situs inversus
[68,133]. Therefore, TRPP2 appears to have functions whose
manifestations during embryonic development (revealed in
homozygous knockout mice) differ from those after develop-
ment (revealed by the delayed, second-hit-mediated loss of
TRPP2 function in ADPKD patients). The kidneys of hetero-
zygous TRPP2 knockout mice do not exhibit a prominent cystic
phenotype [68]. These results demonstrate that loss of TRPP2 is
sufficient to cause renal cysts and support the two-hit model.
Further evidence for the two-hit model comes from a unique
strain of mice carrying a Pkd2 allele (WS25) that is prone to
genomic rearrangement [68]. The WS25 allele produces
wildtype TRPP2 protein. However, during life it can rearrange
to produce a null allele, mimicking somatic mutations.
Compound heterozygous Pkd2WS25/− mice represent the most
authentic model of human ADPKD to date in that they are
viable and develop cysts throughout adult life, resembling the
human ADPKD phenotype [68]. Rodent models have proven to
be very useful in the analysis of the pathological features of
ADPKD, as well as in the development and evaluation of new
therapeutic strategies [166]. Conditional inactivation of TRPP2
using the Cre-lox system will take this one step further, since it
will allow us to study the tissue-specific functions of TRPP2 in
adult animals and the importance of the timing of gene
inactivation. However, due to the complexity of these models,
studies on the signal transduction networks underlying
cystogenesis continue to be very challenging.
Until recently, the study of TRPP2 function within complex
signaling networks in vivo has been hampered by the lack of
genetically tractable model organisms. The discovery of TRPP2
homologs in C. elegans, Drosophila melanogaster and zebra-
fish has now greatly facilitated the study of TRPP2 signaling
pathways in vivo [62–64,67]. In zebrafish, the expression
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similar to mammalian TRPP2 [66]. Morpholino-antisense-
mediated disruption of zebrafish polycystin-2 gave rise to
multiple phenotypes including pronephric cysts and organ
laterality defects [66]. Furthermore, large scale mutagenesis in
zebrafish has confirmed the role of known cyst genes like HNF-
1β as well as identified new “cilia genes” that are involved in
cyst formation [67]. The C. elegans TRPP2 homolog (pkd-2) is
expressed in ciliated sensory neurons [62]. Worm pkd-2
function appears to be essential for stereotyped male mating
behavior and it functions in a common pathway with Lov-1, the
worm homolog of polycystin-1 [61,62]. In Drosophila the
TRPP2 homolog AMO is localized to the sperm tail, a ciliated
structure, and is essential for male fertility [63,64]. Loss of
function of AMO does not affect sperm development, or
transfer of sperm into the uterus. Rather, there is a defect in the
directed movement of sperm from the uterus to sperm storage
organs, which is known to be essential for reproductive success
in flies [64]. Thus, in worms and in flies TRPP2 appears to have
a sensory role in ciliated structures. Whether chemical or
mechanical signals activate the channel in these organisms
remains to be shown. Although the anthropocentric mind may
ask why one should spend time (and money) studying genes
involved in kidney disease in organisms that have no kidneys,
using these model organisms will likely prove to be very useful
in elucidating TRPP2 signaling pathways in vivo. Due to the
powerful tools for genetic manipulation, many fundamental
signaling pathways have been originally identified in Droso-
phila and C. elegans. More than half of human disease genes
are evolutionary conserved in these organisms. Drosophila and
C. elegans TRP channels share many basic features with
mammalian TRP family members. This suggests that particular
classes of Drosophila and C. elegans TRP channels can provide
considerable insight into the function of their mammalian
counterparts. Unbiased forward genetic screens in these model
organisms are underway to identify new upstream and down-
stream components in the TRPP2 signaling pathway in vivo.
9. Conclusions and future perspectives
Since the identification of TRPP2 in the past decade there
has been considerable progress in our understanding of the
cellular and subcellular functions of this exceptionally versatile
ion channel. TRPP2 and polycystin-1 form the core of a
signaling pathway that uses Ca2+ as a second messenger, and it
has become evident that TRPP2 exhibits distinct signaling
functions in different subcellular compartments. However, the
diversity of the processes in which these signaling mechanisms
appear to be involved highlights the remaining questions. What
are the specific molecular cues that activate these pathways?
What are their downstream effectors and what additional factors
are responsible for adapting these mechanisms to the unique
requirements of each tissue?
A multidisciplinary approach using biochemistry, electro-
physiology, cell biology, and animal models ranging from C.
elegans to mice will be required to address these complex
issues. Thus, in order to address the fundamental question whyloss of TRPP2 channel function ultimately results in such
profound changes in organ architecture, we will need to
integrate information gathered from the analysis of data sets
as diverse as single channel recordings, proteomics, TRPP2
signaling networks, worm sex, fly sperm and conditional mouse
models. This endeavor would undoubtedly benefit from the
continuing collaborative efforts of geneticists, physiologists,
cell biologists and developmental biologists. Future results not
only promise to improve our understanding of ADPKD
pathogenesis, but will also provide insights into the enigmatic
mechanisms of Ca2+ signaling specificity. These are exciting
times for TRPP2 research.
It is encouraging that first therapeutic approaches have
emerged from basic research studies (reviewed in [167]).
Ultimately, improved understanding of ADPKD pathogenesis
and the availability of animal models of the human disease will
provide an excellent opportunity for the development of rational
therapies.
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